GlaxoSmithKline has launched an internal investigation into potential violations of the Foreign Corrupt Practices Act for alleged bribery payments made to doctors in Iraq, nine months after becoming embroiled in a similar corruption probe for improper payments made in China.
GSK is investigating claims into whether some of its employees hired government-employed doctors and pharmacists in Iraq as paid sales representatives in exchange for promoting and prescribing its drugs, according to e-mails obtained by the Wall Street Journal.
